Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type

Annals of Oncology

Volumn 20, Issue 6, 2009, Pages 1086-1093

  Stathis, A ^a,b   Chini, C ^b   Bertoni, F ^a   Proserpio, I ^b   Capella, C ^c   Mazzucchelli, L ^d   Pedrinis, E ^d   Cavalli, F ^a   Pinotti, G ^b   Zucca, E ^a,e  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b UO Oncologia Medica   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d INSTITUTE OF PATHOLOGY   (Switzerland)

^e REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Gastric MALT lymphoma; H. pylori eradication; Long term outcome; Watch and wait policy

Indexed keywords

AMOXICILLIN; CHLORAMBUCIL; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PREDNISONE; PROTON PUMP INHIBITOR; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; DISEASE CONTROL; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRECTOMY; GASTRIC MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 66149122992     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn760     Document Type: Article

References (41)

1. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: What has changed over the past 10 years? Br J Haematol 2007; 136: 521-538.
2. Nakamura S, Matsumoto T, Iida M et al. Primary gastrointestinal lymphoma in Japan: A clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 2003; 97: 2462-2473.
3. Koch P, Probst A, Berdel WE et al. Treatment results in localized primary gastric lymphoma: Data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050-7059.
4. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410-1416.
5. Zucca E, Bertoni F, Roggero E et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998; 338: 804-810.
6. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000; 96: 410-419.
7. Du MQ, Isaacson PG. Gastric MALT lymphoma: From aetiology to treatment. Lancet Oncol 2002; 3: 97-104.
8. Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl 2): Ii70-ii71.
9. Ferreri AJ, Zucca E. Marginal-zone lymphoma. Crit Rev Oncol Hematol 2007; 63: 245-256.
10. Bertoni F, Zucca E. State-of-the-art therapeutics: Marginal-zone lymphoma. J Clin Oncol 2005; 23: 6415-6420.
11. Pinotti G, Zucca E, Roggero E et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997; 26: 527-537.
12. Thieblemont C, Dumontet C, Bouafia F et al. Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: A retrospective study of patients treated during 1976-2001. Leuk Lymphoma 2003; 44: 257-262.
13. Roggero E, Zucca E, Pinotti G et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122: 767-769.
14. Rohatiner A, d'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
15. Isaacson PG, Muller-Hermelink HK, Piris MA et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press 2001; 157-160.
16. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
17. Cheson BD, Pfistner B, Juweid ME et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
18. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72: 511-518.
19. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons 1980.
20. Zucca E, Pinotti G, Roggero E et al. High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol 1995; 6: 726-728.
21. Fischbach W, Goebeler-Kolve ME, Dragosics B et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series. Gut 2004; 53: 34-37.
22. Wundisch T, Thiede C, Morgner A et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018-8024.
23. Cohen SM, Petryk M, Varma M et al. Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue. Oncologist 2006; 11: 1100-1117.
24. Bertoni F, Conconi A, Capella C et al. Molecular follow-up in gastric mucosaassociated lymphoid tissue lymphomas: Early analysis of the LY03 cooperative trial. Blood 2002; 99: 2541-2544.
25. Montalban C, Santon A, Redondo C et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): A 10year updated follow-up of a prospective study. Ann Oncol 2005; 16: 1539-1544.
26. Thiede C, Wundisch T, Alpen B et al. Persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001; 19: 1600-1609.
27. Neubauer A, Thiede C, Morgner A et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997; 89: 1350-1355.
28. Copie-Bergman C, Gaulard P, Lavergne-Slove A et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003; 52: 1656.
29. Savio A, Franzin G, Wotherspoon AC et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction, or both? Blood 1996; 87: 1255-1260.
30. Nobre-Leitao C, Lage P, Cravo M et al. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: A study controlled by endoscopic ultrasonography. Am J Gastroenterol 1998; 93: 732-736.
31. Steinbach G, Ford R, Glober G et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999; 131: 88-95.
32. Ruskone-Fourmestraux A, Dragosics B, Morgner A et al. Paris staging system for primary gastrointestinal lymphomas. Gut 2003; 52: 912-913.
33. Kim JS, Chung SJ, Choi YS et al. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer 2007; 96: 1324-1328.
34. Isaacson PG, Diss TC, Wotherspoon AC et al. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibiotics. Gastroenterology 1999; 117: 750-751.
35. Fischbach W, Goebeler-Kolve M, Starostik P et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002; 360: 547-548.
36. Raderer M, Streubel B, Wohrer S et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006; 55: 616-618.
37. Gospodarowicz M, Tsang R. Radiation therapy of mucosa-associated lymphoid tissue (MALT) lymphomas. In Zucca E (ed): MALT Lymphomas. Georgetown, TX: Landes Bioscience 2004; 104-129.
38. Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: A review of treatment options. Int J Radiat Oncol Biol Phys 2000; 46: 1093-1103.
39. Martinelli G, Laszlo D, Ferreri AJ et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for antiHelicobacter pylori therapy. J Clin Oncol 2005; 23: 1979-1983.
40. Conconi A, Martinelli G, Thieblemont C et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741-2745.
41. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: Experience from a large international series. Gut 2007; 56: 1685-1687.